In this panel, Dr. Stephen Gitelman facilitated the discussion with Prof Loredana Marcovecchio, Prof Holly O’Donnell, and Prof Jacques Beltrand. The speakers discussed the benefits of early detection of T1D in young people and how insights from screening initiatives can inform global programs, strategies for navigating conversations with individuals considering screening, and the importance of beta-cell preservation in the context of current and emerging therapeutic approaches.
This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.